-transparent.png){kind=logo}
Indolmycin specifically prevents the formation of tryptophanyl-tRNA in a prokaryotic system in vitro using Escherichia coli enzymes. However, the drug has little effect in an eukaryotic system in vitro (rat liver enzymes). Analysis of the type of inhibition revealed that indolmycin competes with tryptophan as a pure competitive inhibitor of prokaryotic tryptophanyl-tRNA ligase.
Related Publications
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
September 2009,
Antimicrobial agents and chemotherapy,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
January 2016,
The Journal of biological chemistry,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
November 2022,
European journal of medicinal chemistry,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
June 2002,
The Journal of biological chemistry,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
January 1976,
Molekuliarnaia biologiia,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
December 1993,
European journal of cell biology,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
January 1993,
Biochimie,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
July 1973,
Biochimica et biophysica acta,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
January 1987,
Molekuliarnaia biologiia,
R G Werner, and
L F Thorpe, and
W Reuter, and
K H Nierhaus
May 2002,
Trends in biochemical sciences,
